July 17, 2017 8:27 a.m. ET
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
November 30, 2016
Kocal Consulting Corporation Celebrates New Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-Pharm World
November 11, 2015
CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient.
Cancer Free After RVLYSIS
August 26, 2013
CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors
More Than 50% Using PRO-RVLYSIS®
August 16, 2012
CZ BioMed Corp. Announces Licensing of Key U.S. Patent From The University of Texas Health Science Center at San Antonio Regarding the Use of Respiratory Syncytial Virus (RSV) for Anti-Cancer Oncolytic Treatments
January 25, 2012
Prostate Cancer Trials Underway Overseas PRO-RVLYSIS(R) CZ BioMed Corp.
September 22, 2011
Prostate Cancer Cure United States Patent Application – CZ BioMed Corp.
September 8, 2011
PROGRESS IN PANCREATIC CANCER CURE RESEARCH PANRVLYSIS®
Aug 23, 2011
CZ BioMed Corp. Names Internationally Renowned Dr. Ronald E. Wheeler, M.D. as Medical Director of its Scientific and Medical Advisory Boards
May 3, 2011
BREAST CANCER CURE INTERNATIONAL PATENT APPLICATION # PCT/US2011/000602 CZ BioMed Corp.
Oct 12, 2010 12:23 ET
Research for Cancer Cure — RVLYSIS® CZ BioMed Corp.